
Glimmeh-M 1 Tablet SR
Marketer
Vibdrugs Biosciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimmeh-M 1 Tablet SR
Diabetic patients using GlucoDuo-1 SR, a dual-action antidiabetic medication, manage type 2 diabetes mellitus. This combination therapy regulates blood glucose in adults. GlucoDuo-1 SR tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use, even with controlled blood sugar, is crucial; discontinuation without medical advice risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with fast-acting glucose sources (e.g., sugary foods, juice). Alcohol increases this risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating individuals must seek medical advice before use. Regular blood glucose checks, along with potential blood tests for blood cell counts and liver function, are recommended by your physician.
Uses of Glimmeh-M 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimmeh-M 1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimmeh-M 1 Tablet SR should be administered with a meal.
Common Side effects of Glimmeh-M 1 Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimmeh-M 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimmeh-M 1 Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. Consume with a meal.
How Glimmeh-M 1 Tablet SR works:
Glimmeh-M SR, a single-tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Glimmeh-M 1 Tablet SR.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimmeh-M tablet (1 mg) might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for advice.
Breast feedingUNSAFE
Prolonged-release Glimmeh-M tablets (1 mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Glimmeh-M 1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Glimmeh-M 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Glimmeh-M 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. In patients exhibiting mild to moderate liver dysfunction, initiate Glimmeh-M 1 Tablet SR therapy with a reduced starting dose; its use is contraindicated in those with severe liver disease.
What if you forget to take Glimmeh-M 1 Tablet SR :
Should you forget a Glimmeh-M 1 Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimmeh-M 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
